Publicaciones en colaboración con investigadores/as de University of Pisa (107)

2024

  1. CLO24-088: Efficacy of Fruquintinib in Less Heavily Pretreated Patients (Pts) With Metastatic Colorectal Cancer (mCRC): Profile-Matched Data From FRESCO and FRESCO-2

    Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 22, Núm. 25

  2. Corrigendum to “ESPEN practical guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease” [Clin Nutr 43 (2024) 2238–2254, (S0261561424002802), (10.1016/j.clnu.2024.08.002)]

    Clinical Nutrition

  3. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

    Nature Medicine, Vol. 30, Núm. 1, pp. 271-278

  4. ESPEN practical guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2238-2254

  5. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis

    European Journal of Cancer, Vol. 207

  6. Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study

    Journal of Infection, Vol. 89, Núm. 6

  7. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International

  8. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

    HemaSphere

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

    Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255

  3. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

    Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553

  4. Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database

    Cancers, Vol. 15, Núm. 16

  5. Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week

    Journal of the American College of Cardiology, Vol. 81, Núm. 5, pp. 505-514

  6. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

    The Lancet, Vol. 402, Núm. 10395, pp. 41-53

  7. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  8. Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN

    Clinical Nutrition, Vol. 42, Núm. 4, pp. 443-457

  9. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65

  10. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  11. Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study

    Joint Bone Spine, Vol. 90, Núm. 4

  12. Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis

    International Journal of Cardiology, Vol. 370, pp. 58-64